{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:25:39Z","timestamp":1781285139539,"version":"3.54.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":892,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI131471"],"award-info":[{"award-number":["U19AI131471"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1111\/ajt.15873","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T06:52:53Z","timestamp":1592203973000},"page":"2-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S4","title":["Experimental modeling of desensitization: What have we learned about preventing AMR?"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-5472","authenticated-orcid":false,"given":"Jean","family":"Kwun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-385X","authenticated-orcid":false,"given":"Stuart","family":"Knechtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1111\/ajt.15873_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajt.15274","article-title":"OPTN\/SRTR 2017 annual data report: kidney","volume":"19","author":"Hart","year":"2019","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellares","year":"2012","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib3","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1681\/ASN.2014060588","article-title":"Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients","volume":"26","author":"Halloran","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15873_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau0143","article-title":"Translational impact of NIH-funded nonhuman primate research in transplantation","volume":"11","author":"Knechtle","year":"2019","journal-title":"Sci Transl Med."},{"key":"10.1111\/ajt.15873_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trre.2019.03.002","article-title":"Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation","volume":"33","author":"Fitch","year":"2019","journal-title":"Transplant Rev (Orlando)."},{"key":"10.1111\/ajt.15873_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1600-6143.2006.01307.x","article-title":"Acute and chronic vascular rejection in nonhuman primate kidney transplantation","volume":"6","author":"Wieczorek","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib7","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1600-6143.2009.02693.x","article-title":"A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy","volume":"9","author":"Aoyagi","year":"2009","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.TP.0000158426.64631.ED","article-title":"Costimulation blockade followed by a 12-week period of cyclosporine A facilitates prolonged drug-free survival of rhesus monkey kidney allografts","volume":"79","author":"Haanstra","year":"2005","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib9","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1600-6143.2006.01351.x","article-title":"Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates","volume":"6","author":"Smith","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib10","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1600-6143.2008.02303.x","article-title":"Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys","volume":"8","author":"Smith","year":"2008","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00002371-199603000-00001","article-title":"A new reagent for the induction of T-cell depletion, anti-CD3-CRM9","volume":"19","author":"Neville","year":"1996","journal-title":"J Immunother Emphasis Tumor Immunol."},{"key":"10.1111\/ajt.15873_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00007890-199807150-00002","article-title":"Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9","volume":"66","author":"Armstrong","year":"1998","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.TP.0000075788.72614.D4","article-title":"Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection","volume":"76","author":"Torrealba","year":"2003","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/9536","article-title":"Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates","volume":"5","author":"Kirk","year":"1999","journal-title":"Nat Med."},{"key":"10.1111\/ajt.15873_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00007890-200210150-00006","article-title":"Anti-CD40 therapy extends renal allograft survival in rhesus macaques","volume":"74","author":"Pearson","year":"2002","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00007890-199501000-00018","article-title":"Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys","volume":"59","author":"Kawai","year":"1995","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00007890-199709150-00008","article-title":"Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys","volume":"64","author":"Kimikawa","year":"1997","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/00007890-199706150-00014","article-title":"Postoperative production of anti-donor antibody and chronic rejection in renal transplantation","volume":"63","author":"Abe","year":"1997","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib19","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1097\/00007890-199912150-00022","article-title":"Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance","volume":"68","author":"Kawai","year":"1999","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00007890-200007270-00023","article-title":"Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates","volume":"70","author":"Kawai","year":"2000","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.tp.0000234786.26511.a4","article-title":"Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance\/long-term observations in nonhuman primates","volume":"82","author":"Boskovic","year":"2006","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/tri.13549","article-title":"B cells in transplant tolerance and rejection: friends or foes?","volume":"33","author":"Schmitz","year":"2020","journal-title":"Transpl Int."},{"key":"10.1111\/ajt.15873_bib23","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI41861","article-title":"Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys","volume":"120","author":"Kelishadi","year":"2010","journal-title":"J Clin Invest."},{"key":"10.1111\/ajt.15873_bib24","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1111\/ajt.15873_bib25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nm1673","article-title":"B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates","volume":"13","author":"Liu","year":"2007","journal-title":"Nat Med."},{"key":"10.1111\/ajt.15873_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007890-199701150-00002","article-title":"FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts","volume":"63","author":"Knechtle","year":"1997","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0039-6060(98)70151-5","article-title":"Primate renal transplants using immunotoxin","volume":"124","author":"Knechtle","year":"1998","journal-title":"Surgery."},{"key":"10.1111\/ajt.15873_bib28","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/j.1600-6143.2012.04074.x","article-title":"Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques","volume":"12","author":"Page","year":"2012","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib29","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.4049\/jimmunol.1001655","article-title":"CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production","volume":"185","author":"Zimmerer","year":"2010","journal-title":"J Immunol."},{"key":"10.1111\/ajt.15873_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ajt.12565","article-title":"Alloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms","volume":"14","author":"Zimmerer","year":"2014","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ajt.12526","article-title":"Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature."},{"key":"10.1111\/ajt.15873_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00007890-199601150-00002","article-title":"CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway","volume":"61","author":"Larsen","year":"1996","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib34","doi-asserted-by":"crossref","first-page":"8789","DOI":"10.1073\/pnas.94.16.8789","article-title":"CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates","volume":"94","author":"Kirk","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/ajt.15873_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ajt.15661","article-title":"First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody","volume":"20","author":"Espi\u00e9","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib36","first-page":"4594","article-title":"CTLA4Ig inhibits alloantibody responses to repeated blood transfusions","volume":"88","author":"Ibrahim","year":"1996","journal-title":"Blood."},{"key":"10.1111\/ajt.15873_bib37","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.4049\/jimmunol.159.11.5187","article-title":"Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation","volume":"159","author":"Levisetti","year":"1997","journal-title":"J Immunol."},{"key":"10.1111\/ajt.15873_bib38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.etp.2013.02.005","article-title":"Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta)","volume":"65","author":"Page","year":"2013","journal-title":"Exp Toxicol Pathol."},{"key":"10.1111\/ajt.15873_bib39","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2006.060772","article-title":"Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production","volume":"66","author":"Lavie","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"10.1111\/ajt.15873_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/annrheumdis-2012-202071","article-title":"Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren\u2019s syndrome: data from a placebo-controlled clinical trial","volume":"72","author":"Pollard","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"10.1111\/ajt.15873_bib41","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1038\/jid.2009.27","article-title":"Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris","volume":"129","author":"Nagel","year":"2009","journal-title":"J Invest Dermatol."},{"key":"10.1111\/ajt.15873_bib42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/TP.0b013e318246621d","article-title":"Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS\/BAFF","volume":"93","author":"Parsons","year":"2012","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.smim.2012.03.001","article-title":"New wine in old bottles: expanding roles for B cells in transplantation tolerance","volume":"24","author":"Naji","year":"2012","journal-title":"Semin Immunol."},{"key":"10.1111\/ajt.15873_bib44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2009.02710.x","article-title":"BAFF is increased in renal transplant patients following treatment with alemtuzumab","volume":"9","author":"Bloom","year":"2009","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ajt.13045","article-title":"Neutralizing BAFF\/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model","volume":"15","author":"Kwun","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib46","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/S0140-6736(18)30984-X","article-title":"Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial","volume":"391","author":"Banham","year":"2018","journal-title":"Lancet."},{"key":"10.1111\/ajt.15873_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.2010.75","article-title":"Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons","volume":"78","author":"Tillou","year":"2010","journal-title":"Kidney Int."},{"key":"10.1111\/ajt.15873_bib48","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/bloodadvances.2017010991","article-title":"Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates","volume":"1","author":"Kwun","year":"2017","journal-title":"Blood Adv."},{"key":"10.1111\/ajt.15873_bib49","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/ajt.15067","article-title":"Dual targeting: combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients","volume":"19","author":"Burghuber","year":"2019","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI110005","article-title":"A unique cell surface antigen identifying lymphoid malignancies of B cell origin","volume":"67","author":"Nadler","year":"1981","journal-title":"J Clin Invest."},{"key":"10.1111\/ajt.15873_bib51","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"10.1111\/ajt.15873_bib52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.0105-2896.2006.00380.x","article-title":"Adaptation of humoral memory","volume":"211","author":"Hofer","year":"2006","journal-title":"Immunol Rev."},{"key":"10.1111\/ajt.15873_bib53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ki.2014.261","article-title":"A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation","volume":"87","author":"Jackson","year":"2015","journal-title":"Kidney Int."},{"key":"10.1111\/ajt.15873_bib54","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.20040719","article-title":"Targeting plasma cells in autoimmune diseases","volume":"199","author":"Tarlinton","year":"2004","journal-title":"J Exp Med."},{"key":"10.1111\/ajt.15873_bib55","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med."},{"key":"10.1111\/ajt.15873_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib57","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.transproceed.2008.10.073","article-title":"Proteasome inhibition reduces donor-specific antibody levels","volume":"41","author":"Everly","year":"2009","journal-title":"Transpl Proc."},{"key":"10.1111\/ajt.15873_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib60","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2016070727","article-title":"Humoral compensation after bortezomib treatment of allosensitized recipients","volume":"28","author":"Kwun","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15873_bib61","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1681\/ASN.2017040443","article-title":"Targeting plasma cells with proteasome inhibitors: principles from primates","volume":"28","author":"Woodle","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15873_bib62","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A Randomized trial of bortezomib in late antibody-mediated kidney transplant rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15873_bib63","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ni.1954","article-title":"Plasma cells negatively regulate the follicular helper T cell program","volume":"11","author":"Pelletier","year":"2010","journal-title":"Nat Immunol."},{"key":"10.1111\/ajt.15873_bib64","first-page":"1521","article-title":"CD28, a marker associated with tumoral expansion in multiple myeloma","volume":"4","author":"Robillard","year":"1998","journal-title":"Clin Cancer Res."},{"key":"10.1111\/ajt.15873_bib65","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4049\/jimmunol.1100016","article-title":"CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment","volume":"187","author":"Nair","year":"2011","journal-title":"J Immunol."},{"key":"10.1111\/ajt.15873_bib66","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1182\/blood-2006-03-012542","article-title":"CD28-mediated regulation of multiple myeloma cell proliferation and survival","volume":"109","author":"Bahlis","year":"2007","journal-title":"Blood."},{"key":"10.1111\/ajt.15873_bib67","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20110040","article-title":"Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells","volume":"208","author":"Rozanski","year":"2011","journal-title":"J Exp Med."},{"key":"10.1111\/ajt.15873_bib68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2006.01.012","article-title":"Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells","volume":"24","author":"Delogu","year":"2006","journal-title":"Immunity."},{"key":"10.1111\/ajt.15873_bib69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI0214110","article-title":"Short-circuiting long-lived humoral immunity by the heightened engagement of CD40","volume":"109","author":"Erickson","year":"2002","journal-title":"J Clin Invest."},{"key":"10.1111\/ajt.15873_bib70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4049\/jimmunol.0901694","article-title":"Augmented antibody response with premature germinal center regression in CD40L transgenic mice","volume":"185","author":"Kishi","year":"2010","journal-title":"J Immunol."},{"key":"10.1111\/ajt.15873_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2018.02.008","article-title":"Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: a systematic review","volume":"125","author":"Mushtaq","year":"2018","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1111\/ajt.15873_bib72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/ajt.15613","article-title":"A prospective, iterative, adaptive trial of carfilzomib-based desensitization","volume":"20","author":"Tremblay","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.15873_bib73","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1681\/ASN.2019030304","article-title":"Pretransplant desensitization with costimulation blockade and proteasome inhibitor reduces DSA and delays antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients","volume":"30","author":"Ezekian","year":"2019","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15873_bib74","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/TP.0000000000001588","article-title":"Crosstalk between T and B cells in the germinal center after transplantation","volume":"101","author":"Kwun","year":"2017","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib75","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MOT.0000000000000656","article-title":"The past, present, and future of costimulation blockade in organ transplantation","volume":"24","author":"Schroder","year":"2019","journal-title":"Curr Opin Organ Transplant."},{"key":"10.1111\/ajt.15873_bib76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"10.1111\/ajt.15873_bib77","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1681\/ASN.2018121254","article-title":"Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use","volume":"30","author":"Kwun","year":"2019","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15873_bib78","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1615\/CritRevImmunol.v19.i5-6.10","article-title":"Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories","volume":"19","author":"Kirk","year":"1999","journal-title":"Crit Rev Immunol."},{"key":"10.1111\/ajt.15873_bib79","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1600-065X.2003.00081.x","article-title":"Crossing the bridge: large animal models in translational transplantation research","volume":"196","author":"Kirk","year":"2003","journal-title":"Immunol Rev."},{"key":"10.1111\/ajt.15873_bib80","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1084\/jem.177.4.979","article-title":"Evolutionary conservation of major histocompatibility complex-DR\/peptide\/T cell interactions in primates","volume":"177","author":"Geluk","year":"1993","journal-title":"J Exp Med."},{"key":"10.1111\/ajt.15873_bib81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0198-8859(92)90092-2","article-title":"Evolutionary stability of transspecies major histocompatibility complex class II DRB lineages in humans and rhesus monkeys","volume":"35","author":"Slierendregt","year":"1992","journal-title":"Hum Immunol."},{"key":"10.1111\/ajt.15873_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v15.i1.10","article-title":"The evolution of major histocompatibility class I genes in primates","volume":"15","author":"Watkins","year":"1995","journal-title":"Crit Rev Immunol."},{"key":"10.1111\/ajt.15873_bib83","first-page":"31","article-title":"A primate model of hyperacute renal allograft rejection","volume":"79","author":"Busch","year":"1975","journal-title":"Am J Pathol."},{"key":"10.1111\/ajt.15873_bib84","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/S0041-1345(97)00501-0","article-title":"Chronic rejection in rhesus monkey kidney allografts","volume":"29","author":"Schuurman","year":"1997","journal-title":"Transplant Proc."},{"key":"10.1111\/ajt.15873_bib85","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0041-1345(98)00191-2","article-title":"Changes in T-cell subsets after renal transplantation in nonimmunosuppressed baboons","volume":"30","author":"Linley","year":"1998","journal-title":"Transplant Proc."},{"key":"10.1111\/ajt.15873_bib86","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00007890-198911000-00002","article-title":"Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies","volume":"48","author":"Nocera","year":"1989","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15873_bib87","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15873","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15873","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15873","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522225921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522225921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:29:02Z","timestamp":1761629342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522225921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":87,"alternative-id":["S1600613522225921"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15873","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental modeling of desensitization: What have we learned about preventing AMR?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}